Replies to post #50 on Alexion Pharmaceuticals, Inc. (ALXN)

[stocktrader001]

ALXN 3 years chart

[surf1944]

Alexion (ALXN), with its only product Soliris, bases its strategy on treating ultra-rare diseases. This company established itself quite quickly on the market where it had no competitor for its niche. Soliris holds a world record for the most expensive medicine. This certainly helps Alexion's incredible earnings growth rate.

http://seekingalpha.com/article/489571-questcor-a-strong-play-in-pharma?source=yahoo